MassARRAY SARS-CoV-2/Flu Panel (RUO)

High-Throughput, Low-Cost Detection of SARS-CoV-2, Influenza A, and Influenza B RNA

With unprecedented sample volumes expected, this flu season poses critical testing challenges for laboratories, which must reliably and efficiently differentiate between SARS-CoV-2 and influenza RNA.

Current detection methods are either too expensive or are constrained by the number of samples that can be processed. The MassARRAY^® SARS-CoV-2/Flu Panel from Agena Bioscience^® addresses these concerns.

MAXIMIZE THROUGHPUT – Process up to thousands of samples in a day with the MassARRAY System.
ENSURE ACCURATE DETECTION – The panel includes dual SARS-CoV-2 targets for redundancy, and a sophisticated pan-assay design to detect all influenza A subtypes (including H1N1 and H3N2) and influenza B lineages.
SAVE TIME & MONEY – Low-cost reagents and automated results reporting saves lab resources.
SECURE RELIABLE SUPPLY – Immediate availability of instruments and reagents.

The MassARRAY SARS-CoV-2/Flu Panel is available for Research Use Only.